Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.

Announcements

388

Total raised

£13.0B

disclosed amounts

Series B
£16.9M

NordicNinja led the financing round alongside Lightspeed, Superangel, and several prominent angel investors.

"This Series B round is a huge vote of confidence in the untapped potential of investing in Europe and Lightyear’s ability to make the difference. Driving meaningful progress in this market means removing barriers to entry and demystifying investing for ordinary people. That’s why we feel so strongly about our vision for AI and the future of investing. Europe is still a society of savers with completely independent tax systems, different regulations and complicated infrastructure – it’s definitely not a one-size-fits-all solution. We’re making huge leaps forward in our mission to enable 750 million Europeans to build meaningful wealth, so it’s an incredibly exciting time for the business right now."
— Martin Sokk, Co-founder and CEO
Series B
£25.9M

The Series B round was led by Dawn Capital with participation from Meritech Capital.

"Introducing customers to Business Premium, and providing them with the most valuable licensing, is only the first step. The other is to make sure those licenses stay configured and up to date. Trying to do that across 300 customers is impossible without inforcer"
— Gary Melvin
Series B
£45.0M

The digital health provider has raised a £45m Series B extension and growth capital package led by Big Pi Ventures and HSBC Innovation Banking.

"Our latest funding is a testament to both our commercial performance and belief in our long-term vision for providing personalised, preventative health at scale. With the fresh conviction of Big Pi Ventures, Endeavor Catalyst and HSBC Innovation Banking – as well as the continued backing of White Star Capital and our long-term investors – we are now perfectly positioned to expand our reach, deepen our clinical capabilities, and accelerate innovation to help our patients live happier, healthier, longer lives."
— Sokratis Papafloratos, CEO